secwatch.observer — SEC 8-K summary
======================================

Issuer:     GT Biopharma, Inc. (GTBP)
CIK:        0000109657
Form:       8-K
Filed at:   2021-11-01T23:59:59+00:00
Accession:  0001654954-21-011550
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GT Biopharma files 8-K to announce updated corporate presentation on website; no specifics disclosed
--------------------------------------------------------------------------------

- Filing states corporate presentation as of Nov 1, 2021 was posted to company website.
- Presentation filed as Exhibit 99.1 but full content not provided in filing text.
- No financial results, guidance, or operational changes mentioned in the filing.
- Ticker: GTBP; common stock listed on Nasdaq.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/109657/000165495421011550/0001654954-21-011550-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/109657/000165495421011550/gtbp_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-21-011550

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer